Abstract:Abstract CRSIPR-Cas9 system has opened up the avenue to efficient genome editing 1–4 . However, together with known off-target effects, several concerns of current CRISPR-Cas9 platform, including severe DNA damage, cytotoxicity, and large genomic alteration, have emerged in recent reports 5–7 and establish a formidable obstacle to precisely model allele dosage effects of disease mutations and risk variants, especially mono-allelic effects, and correct them. Here, by developing an allele-specific indel monitor system (AIMS), we demonstrate that small and simple modification of conventional single-guide RNAs (sgRNAs) enable programmable tuning of CRISPR-Cas9 activities and alleviate such adverse effects. AIMS, which visualizes various indel events in two alleles separately in living cells, is convenient and accurate to determine the in vitro editing efficiency and revealed frequent mosaicism during genome editing. Using AIMS, we show that adding cytosine stretches to the 5’ end of conventional sgRNA efficiently reduced Cas9 activity in a length dependent manner. By combining systematic experiments and computational modeling, we established the quantitative relationships between the length of cytosine extension and multiple aspects of CRISPR-Cas9 system. In general, short cytosine extension dramatically relieves p53-dependent cytotoxicity and suppression of homology-directed repair (HDR) while relatively maintaining on-target activity. Long cytosine extension further decreases on-target activity, thereby maximizing mono-allelic editing, while conventional system typically induces bi-allelic editing. Furthermore, such downregulation of on-target activity contributes to downregulation of relative off-target activity and protection of HDR-allele from second off-target editing. Therefore, cytosine extension method finally enables both single-step generation of heterozygous single-nucleotide disease mutations from homozygous states in mouse ES cells and correction of heterozygous disease mutations in human iPS cells. Taken together, our study proposes updates of standard CRISPR-Cas9 platform in mammalian cells toward precise and safe genome editing in diverse applications.

MOSAIC enables saturation mutagenesis of genes and CRISPR prime editing guide RNA optimization in human cells

[Optimization of CRISPR/Cas9-based multiplex base editing in Corynebacterium glutamicum].

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

MOSAIC: a highly efficient, one-step recombineering approach to plasmid editing and diversification

Efficient CRISPR genome editing and integrative genomic analyses reveal the mosaicism of Cas-induced mutations and pleiotropic effects of gene in an emerging model system

Genome-wide Mapping of Mutations at Single-Nucleotide Resolution for Protein, Metabolic and Genome Engineering

A selectable all-in-one CRISPR prime editing piggyBac transposon allows for highly efficient gene editing in human cell lines

Large-scale multiplexed mosaic CRISPR perturbation in the whole organism

Feasibility for a large scale mouse mutagenesis by injecting CRISPR/Cas plasmid into zygotes

Programmable downsizing of CRISPR-Cas9 activity for precise and safe genome editing

Small Molecules Promote CRISPR-Cpf1-mediated Genome Editing in Human Pluripotent Stem Cells

Maximizing mutagenesis with solubilized CRISPR-Cas9 ribonucleoprotein complexes.

Multiplexed CRISPR technologies for gene editing and transcriptional regulation

CRISPR single base-editing: in silico predictions to variant clonal cell lines

Promoting Cas9 Degradation Reduces Mosaic Mutations in Non-Human Primate Embryos

Multiplex Genome Engineering Using CRISPR/Cas Systems

MOF effectively deliver CRISPR and enhance gene-editing efficiency via MOF’s hydrolytic activity of phosphate ester bonds

Efficient Generation and Correction of Mutations in Human iPS Cells Utilizing mRNAs of CRISPR Base Editors and Prime Editors

A robust and inducible precise genome editing via an all-in-one prime editor in human pluripotent stem cells

Versatile CRISPR/Cas9-mediated mosaic analysis by gRNA-induced crossing-over for unmodified genomes

Multiplex CRISPR/Cas9-based genome engineering enhanced by Drosha-mediated sgRNA-shRNA structure